December 18, 2020
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation. Today’s approval of Tagrisso demonstrates how additional research on therapies approved in later stages of cancer can eventually improve treatment options for patients in earlier stages,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research. “With this approval, patients may be treated with this targeted therapy in an earlier and potentially more curative stage of non-small cell lung cancer.”
SINGAPORE (The Straits Times/ANN): There are some groups of people who should wait to receive a Covid-19 vaccine, including those with a history of severe allergic reactions, said a panel of experts on Thursday (Dec 17).
Serious allergies usually refer to people who, in response to a specific stimulus such as a bee sting or medication, experience swelling around the mouth, eyes or face, have difficulty breathing or experience a serious drop in blood pressure, said Associate Professor Lim Poh Lian, the director of the high-level isolation unit at the National Centre for Infectious Diseases.
Others who belong to certain groups such as pregnant women, immunocompromised persons and those under the age of 16 should also hold off on receiving the shots, as large-scale clinical trials have not involved such volunteers.
Let us be guided by science thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
NAT develops novel kidney analysis device for Singapore patients
NAT develops novel kidney analysis device for Singapore patients 17 December 2020 | News The medtech device called ACT by Zensorium needs no refrigeration while screening and testing for kidney disease
Singapore patients at risk of Chronic Kidney Disease will soon have the option to be tested by ACT by Zensorium, a more accessible early-detection device by Nitto Denko Asia Technical Centre (NAT) currently being tested at Singapore General Hospital (SGH).
End-stage kidney disease is the sixth most common cause of death in Singapore. Each day an average of five new patients are diagnosed and this is likely to rise further with Singapore’s increased prevalence of diabetes and ageing population. Support and funding for innovation and research are key to improve early detection, treatment and management.
Thursday, 17 Dec 2020 10:59 AM MYT
Subscribe to our Telegram channel for the latest updates on news you need to know.
DECEMBER 17 Member of Parliament Tengku Razaleigh Hamzah in his statement last week challenged government ministers, promoters and supporters involved in the ongoing effort to acquire at least one Covid-19 vaccine for Malaysia, be vaccinated first before any members of the Malaysian public.
My parents and I step forward to pick up the gauntlet and volunteer ourselves to be among the first to receive the mRNA vaccines which are being acquired by the Malaysian government, especially if the MP is offering to help with the process. We trust in the science.